Abstract
The N-terminal region of troponin T (TnT) does not bind any protein of the contractile machinery and the role of its hypervariability remains uncertain. In this review we report the evidence of the interaction between TnT and AMP deaminase (AMPD), a regulated zinc enzyme localized on the myofibril. In periods of intense muscular activity, a decrease in the ATP/ADP ratio, together with a decrease in the tissue pH, is the stimulus for the activation of the enzyme that deaminating AMP to IMP and NH3 displaces the myokinase reaction towards the formation of ATP. In skeletal muscle subjected to strong tetanic contractions, a calpain-like proteolytic activity produces the removal in vivo of a 97-residue N-terminal fragment from the enzyme that becomes desensitized towards the inhibition by ATP, leading to an unrestrained production of NH3. When a 95-residue N-terminal fragment is removed from AMPD by trypsin, simulating in vitro the calpain action, rabbit fast TnT or its phosphorylated 50-residue N-terminal peptide binds AMPD restoring the inhibition by ATP. Taking in consideration that the N-terminus of TnT expressed in human as well as rabbit white muscle contains a zinc-binding motif, we suggest that TnT might mimic the regulatory action of the inhibitory N-terminal domain of AMPD due to the presence of a zinc ion connecting the N-terminal and C-terminal regions of the enzyme, indicating that the two proteins might physiologically associate to modulate muscle contraction and ammonia production in fast-twitching muscle under strenuous conditions.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Troponin (Tn) is composed by three proteins, troponin I (TnI), troponin C (TnC) and troponin T (TnT), and this complex binds to tropomyosin (Tm) in the thin filament and regulates the contractile activity of striated myofibrils. When Ca2+ binds to TnC, the TnI inhibition on the actomyosin ATPase is released exposing the myosin-binding sites on F-actin subunits and allowing cross-bridge cycling and fiber contraction [1].
It is well established that the highly conserved C-terminal domains of fast, slow and cardiac TnT have a role in anchoring the Tn complex to Tm on the thin filament [2, 3]. On the contrary, the N-terminal region has a high degree of variability depending on the muscle type and development stage and no clear function has been envisaged [4,5,6,7]. However, it has been reported that the TnT-binding affinity to Tm depends on the sequence and charge of the TnT N-terminal domain [8] further strengthening the hypothesis that TnT might act as a modulator of Tn Ca2+ sensitivity and force production [9] as TnT has been found to activate the actomyosin Mg ATPase in the presence of Tm, but without the other components of the troponin complex [10].
Although a protein that binds in vivo the TnT N-terminal elongated region has not been identified yet, it has been reported that the N-terminal domain of rabbit fast-twitch TnT interacts in vitro with rabbit white muscle AMP deaminase (AMPD) [11]. We have also reported that, following the cleavage of its N-terminal region by a calpain-like protease, rabbit skeletal muscle AMPD is no longer inhibited by ATP and that the increase in its catalytic activity might result in the large muscle ammonia accumulation observed during muscle strenuous exercise [12] and that the inhibition of AMPD by ATP lost by limited proteolysis of the enzyme with trypsin that has similar consequences to those caused by calpain in vivo is restored by adding either purified TnT or its phosphorylated N-terminal peptide [11]. We have also reported that the N-terminal domain of rabbit fast TnT might bind a metal ion by a putative zinc-binding motif [13] and that the N-terminal region of rabbit skeletal muscle AMPD contains a putative zinc-binding site that has a critical role in modulating the enzyme activity by fixing the conformation of the dinuclear catalytic zinc center [14, 15]. These observations led us to hypothesize that the interaction of the TnT N-terminal putative zinc-binding site with the catalytic Zn ion present at the AMPD C-terminus simulates the binding of the enzyme N-terminal and C-terminal regions via the dinuclear Zn center reverting the highly active proteolyzed AMPD form to the less active native conformation. The TnT N-terminal region might therefore have a physiological role in switching off the activated AMPD and allowing recycling of IMP and elimination of ammonia after intense muscle contraction [13].
The hypothesis that the modulation of AMPD in fast skeletal muscle might be physiologically regulated by the interaction with the specific N-terminus of fast TnT is strengthened by the observations reported in this review showing that the variability of the N-terminal segment of TnTs and the expression of different TnT isoforms in muscle tissues, that diverge for function and metabolism, are linked to the co-expression of different isoforms of AMPD. A distinctive relationship between TnT and AMPD is further represented by the isoform switch during muscle development, the adaptation to different contractile necessities or the readjusting to the change of environmental conditions, the restricted proteolysis by calpains of the N-terminal domains containing both a putative zinc-binding site and the nuclear localization shared by both proteins.
Troponin T and the calcium sensitivity of the MgATPase of actomyosin
Contraction of cardiac and skeletal muscle is regulated via the actin filament by tropomyosin (Tm) and the troponin (Tn) complex, composed by TnI, TnC and TnT. It is generally accepted that the calcium sensitivity of the MgATPase of actomyosin is regulated by the Tn complex. TnI is the component of the Tn complex that inhibits the MgATPase of actomyosin by the blocking of the interaction of actin with myosin [16]. As calcium is released, TnI switches to the non-inhibitory mode and the MgATPase is activated. Several results indicate that the switch of the troponin complex on the thin filament is promoted by TnT, the Tm-binding subunit of the Tn complex, that presumably lowers the affinity of TnC for TnI, so removing the inhibition on the MgATPase [17, 18].
The two Tm-binding sites that have been identified on striated muscle TnT are localized, respectively, in the T1 and T2 chymotryptic fragments of rabbit fast TnT [19], the first Tm-binding site (T1 fragment) encompassing the aa residues 79–117 of the longest rabbit fast skeletal muscle TnT variant and the second Tm-binding site (T2 fragment) encompassing the aa residues 179–218 [20] (Fig. 1). Even though the aa sequences of the two Tm-binding sites of fast, slow and cardiac TnT isoforms are conserved in avian and mammalian species, the differences in binding to Tm of the TnT isoforms have been attributed to the hypervariability of the N-terminal region of the different TnT isoforms whose expression is regulated during development and in different muscle types by alternative splicing [20, 27, 28].
Although several authors reported that the deletion of the N-terminal region does not eliminate the TnT activity in the Ca2+ activation of actomyosin ATPase suggesting that the N-terminal variable region might not be essential in the regulation of muscle contraction [29, 30], others reported that after removal of the N-terminal 38 residues of bovine cardiac TnT (TnT39–284) the calcium sensitivity of acto-S1 ATPase decreased [31] and that the fragment TnT1–191 of chicken skeletal muscle promoted the same level of activation of actomyosin MgATPase in the presence of Tm acted by the whole Tn complex in the presence of calcium [10]. The unusually long and charged N-terminal region of the chicken breast muscle T1 fragment of TnT showed a lower affinity to a Tm column compared to the recombinant T1 fragment of rabbit fast TnT, while no differences in affinity for Tm were observed for the C-terminal Tm-binding site within the T2 fragment of fast TnT from the two species. The deletion of the N-terminus of the T1 fragment abolishes the differences among fast, slow and cardiac T1 recombinant fragments in the binding affinity for Tm. These last observations might suggest that the hypervariable N-terminus region might exerts a modulatory role on reducing the affinity for Tm by inducing secondary conformational changes in other domains of TnT [8].
It has been established that TnC and TnI are bound at the C-terminal region of TnT [32, 33]. The binding site of TnI was mapped to the C-terminal region of chicken fast muscle TnT (aa 216–263) using deletion mutants [10].The crystallographic structure of a portion of the TnT C-terminal region in the Tn complex confirmed that the TnI-binding site is localized in the C-terminal region of chicken fast skeletal muscle TnT (aa 200–245, corresponding to aa 190–235 in rabbit fast skeletal muscle TnT) [24], and the binding site of TnC to the 256–270 region of human cardiac TnT (corresponding to aa 244–257 in rabbit fast skeletal muscle TnT) [23] (Fig. 1). However, due to its hypervariable sequence, the N-terminal region has different length and acidity in the various TnT isoforms [2] and might also contain sites of contact for TnC [25, 33] and for TnI [34]. Moreover, it has been shown that the presence of an acidic or a basic chicken fast muscle T1 region in chimera proteins formed with the mouse cardiac T2 region modified the binding to Tm and TnI, corroborating the hypothesis that the TnT N-terminus region might modulate the regulatory role of TnT in the fiber contractility [35]. Interestingly, the strongly acidic N-terminal domain of TnT appears to have an extended conformation that might be accessible to phosphorylation by TnT kinase and by phosphorylase b kinase at Ser-1 [25, 26].
Different TnT isoforms in different muscle fibers
Three different TnT isoforms are encoded from three homologous genes in mammalian and avian cardiac muscle (TNNT2), slow skeletal muscle (TNNT1) and fast skeletal muscle (TNNT3) [6, 36,37,38,39,40] and their expression is tightly regulated during the development of each muscle type.
The three TnT isoforms differ mainly at the N-terminal region [27, 41,42,43], suggesting that N-terminal variable region might have diverse modulatory functions in different types of muscle and at different stages of development, whereas the C-terminal region, where the core activity of TnT in regulating muscle contraction by binding to TnI and TnC has been located, is highly conserved in the vertebrate TnT isoforms.
The comparison of the TnT sequences showed that the TnT isoforms of the same species are less conserved among the three muscle fiber types than across vertebrates [42, 44], suggesting that the N-terminal TnT structural diversities might be linked to the adaptation to different function, metabolism and contraction mechanisms of cardiac, fast, and slow muscle fibers rather than to species evolution.
The hypothesis that the TnT isoforms have diverse modulatory roles in the different types of muscle fiber is well supported by the example of the heart of the toad Bufo. In the toad’s cardiac fibers, TnT1 replaces TnT2 while all other isoforms of the myofilament proteins are expressed as cardiac isoforms [45]. The toad heart was found to be more tolerant to afterload and it exhibited systolic and diastolic velocities faster than the Rana frog heart, suggesting that the expression of the slow skeletal muscle TnT isoform might be an adaptation strategy to overcome heat changes and large variations in the volume of body fluid and blood between rainy and dry seasons [45].
Several mutations in TNNT1, TNNT2, and TNNT3 genes have been reported to cause cardiac and skeletal myopathies. TnT2 containing an abnormal splicing in the N-terminal region has been linked to cardiomyopathies such as inherited dilated cardiomyopathy in turkey hearts expressing a TnT2 missing exon 8 [46]. Similarly, in dog hearts with dilated cardiomyopathy TnT2 does not contain the constitutively expressed exon 7 [27, 42, 47]. Expression of TnT2 lacking exon 4 was detected in failing human hearts [48, 49], diabetic rat hearts [50] and hypertrophic rat hearts [51]. It has also been suggested that the high incidence of inherited cardiomyopathy and heart failure reported in cats and Guinea pigs could be linked to abnormal splicing of the exons encoding for the N-terminal region of TnT2 [47, 52, 53]. In contrast to the numerous mutations found in cardiac TnT2 gene, fewer mutations in TnT3 gene have been reported in skeletal muscle diseases.
The three TnT isoforms appear to play a nonredundant role in muscle fiber types as evidenced by the two observations that the severe nemaline myopathy (NEM, characterized by the presence of rod-shaped or “nemaline” inclusions in skeletal muscle fibers) with infantile death has been linked to a nonsense mutation in human TNNT1 gene that truncates the protein at amino acid 180 deleting the binding sites for TnI, TnC and tropomyosin [54, 55] and that the knock-down of the expression of TnT1 resulted in atrophy, slow-to-fat fiber type switch and reduced resistance to fatigue in the mouse diaphragm muscle [56].
Several mutations in the gene encoding TnT1 have been linked to some NEM. A first nonsense mutation was identified in the Amish NEM (MEN5) and other 6 truncation or internal deletion mutations have been reported in other ethnic groups with myopathies like that of MEN5. The marked clinical variability, ranging from neonatal lethal to mild non-progressive forms, is thought to be linked to the developmental regulation of the TnT isoforms in skeletal muscles. During the embryological development, immature TnT isoforms (embryonic TnT3 and cardiac TnT2) are expressed in skeletal muscle. Around birth and progressing through the first months of life, these are replaced by the adult TnT3 and TnT1 isoforms in fast and slow fibers, respectively. The increase in muscle weakness and atrophy in NEM parallels the time course that the mature TnT1 expression would follow, suggesting that the human muscle viability strictly depends on the expression of normal TnT1 in slow fibers [57].
Recently, one case of severe congenital NEM was linked to the deficient expression of TnT3 resulting in the atrophy the type-2 fibers. A spliced variant of TnT3 was found expressed in other two cases of congenital NEM. While respiratory weakness persisted in those patients with TnT3-related congenital myopathy, limb strength improved over time, suggesting that a postnatal adaptation, such as hypertrophy of slow fibers, might have occurred in certain muscle groups [58, 59].
TnT N-terminal alternative splicing and development
For each of the three muscle-specific TnT genes, alternative RNA splicing during embryonic and postnatal development of skeletal muscle regulates the expression of several isoforms of TnT that differ in the length and acidity of the N-terminal domain [2, 27, 42].
The mammalian cardiac TnT gene is composed by 14 constitutively expressed exons and 3 alternatively spliced exons, two of which encode segments in the N-terminal variable region. The avian cardiac TnT gene contains 16 constitutively spliced exons and 1 N-terminal alternative exon expressed only in embryonic cardiac TnT [37]. In normal cardiac muscle, TnT N-terminal alternative splicing generated 4 and 2 variants in mammals and birds, respectively (reviewed in [7]).
Mammalian fast skeletal muscle TnT gene contains 19 exons. The alternative exons are exons 4, 5, 6, 7, 8 and a fetal exon, all encoding segments in the N-terminal variable region. However, only 13 mouse fast TnT isoforms and 11 chicken fast TnT isoforms differing in the N-terminal variable region are expressed at detectable levels [60,61,62]. In addition to the alternative spliced exons above mentioned, in the fast TnT gene of the avian orders of Galliformes and Craciformes are also present seven P exons, that express seven tandem repeats of a pentapeptide (AHH[A/E]E) at the N-terminus of the protein forming the so-called Tx segment [61, 63, 64]. Although the physiologic function of this Tx segment is not clear yet, it has been hypothesized that it forms a cluster of high-affinity transition metal ion binding sites [65].
The mammalian slow skeletal muscle TnT gene is composed by 13 constitutive exons and one alternatively spliced exon. Alternative splicing of exon 5 in the N-terminal region generates 2 variants of slow TnT [40, 44, 66]. Splicing at two alternative acceptor sites of intron 5 (in mouse) or intron 4 (in chicken) produces an additional single amino acid variant in the slow TnT isoforms [39, 40].
The significance of the N-terminal alternatively spliced TnT variants has yet to be determined. It has been reported that the presence of a more negatively charged TnT N-terminus conferred to isolated fibers from chicken skeletal white muscles a higher myofilament calcium sensitivity [67,68,69]. When reconstituted into skinned cardiac muscle strips, the embryonic cardiac TnT with a more negative N-terminus also confers a higher Ca2+ sensitivity to myosin ATPase and force development in comparison to the adult cardiac TnT with a less negative N-terminal domain [3]. Moreover, the embryonic cardiac TnT conferred high tolerance to acidosis to embryonic and neonatal cardiac muscle [70]. In contrast, the tolerance to acidosis was decreased in transgenic mouse cardiac muscle when fast skeletal muscle TnT with a less negatively charged N-terminus was overexpressed [71].
Whilst cardiac TnT is expressed at significant levels during the embryonic development of avian and mammalian skeletal muscles, during postnatal development a switch from the cardiac to the skeletal muscle TnT isoforms is observed (reviewed in [7]).
During the development of mammalian skeletal muscles, the N-terminal variable region of fast skeletal muscle TnT is subjected to a complex alternative splicing and the inclusion of the fetal and of the other N-terminal alternative exons (exons 4, 6, 7, and 8) decreases as adulthood is reached resulting in a developmental switching from high molecular weight acidic isoforms to low molecular weight basic isoforms [27, 43, 62, 72].
Interestingly, the seven P exons encoding the Tx segment in the N-terminal region is expressed post-hatch only in the adult fast TnT isoforms of some birds [60, 63]. It has been suggested that the high number of negative charges of the Glu residues of the Tx domain might have a role in binding divalent metal ions and that it could act as a calcium reservoir [73]. The N-terminal Tx segment of avian fast TnT, composed by a transition metal-binding histidine-rich sequence HE/AEAH repeated four to seven times, was found to have great affinity for zinc. Since the unique Tx segment of fast TnT is expressed in the fast glycolytic fibers of the breast pectoralis muscle but not in leg muscles of Galliformes [65, 74], a link might exist between the presence of the Tx sequence and the fly capacity of these birds that despite their large flight muscles show little endurance to long fly but a rapid burst fly pattern. Structural changes induced by Zn2+ binding to the Tx segment of chicken breast TnT appeared to alter the binding affinity of TnT to Tm [75]. In addition, the histidine-imidazole groups of the Tx region might change protonation- deprotonation state when cellular pH drops during anaerobic work, possibly modifying not only the conformation of the N-terminal domain of TnT [76] but also the binding of fast TnT to Tm that has been shown to be stabilized by lower pH [60]. The hypothesis that the TnT N-terminus might bind divalent transition metals rather than calcium is strengthened by the observation that in rabbit fast skeletal TnT the N-terminal region contains the sequence of residues 29–50 (29HEPAPEVHVPEEVHEDALEDMR50) where two putative zinc-binding sites (HEXXXE) are located, as it has been ascertained that the similar HEXXXH motif in the N-terminal region of rabbit muscle AMP deaminase represents a zinc-binding site [14]. This observation applies also to the human fast skeletal TnT that reveals the presence of a similar zinc-binding segment (HEEVHE).
Posttranslational modifications of the TnT isoforms
TnT undergoes posttranslational modifications such as phosphorylation and restricted proteolysis at the N-terminus of the protein. Recent mass spectrometry data showed that under physiological conditions the totality of rat adult cardiac TnT is phosphorylated at Ser1 [77, 78] confirming a previous report by Perry [2]. Furthermore, the embryonic mouse cardiac TnT, overexpressed in adult heart, was found to be fully phosphorylated at Ser25 [79], suggesting that the phosphorylation at the N-terminus is conserved in the different isoforms during development and might have an important regulatory role.
In pathological conditions, such as acute ischemia–reperfusion or pressure overload, the phosphorylated 71 amino acid N-terminal variable region of cardiac TnT undergoes a restrictive proteolysis by calpains. The selective removal of the N-terminal domain does not abolish the function of cardiac TnT but alters the binding affinities for TnI, TnC, and tropomyosin and lowers the myosin ATPase activity and myofibril force generation [80, 81] without affecting thin filament calcium sensitivity [82,83,84].
An intriguing and novel role for fast skeletal muscle TnT has been reported by Zhang et al. [85]. Mouse full-length fast skeletal muscle TnT3 was found to shuttle to the nucleus predominantly in the young muscles, whilst its C-terminal fragment predominated in the old fibers. Decreased full-length fast TnT and increased C-terminal domain of fast TnT in the nucleus impaired the expression of the voltage sensor Ca2+ channel α1 subunit reducing muscle force in aging sedentary mice. A calpain inhibitor prevented TnT3 fragmentation and Ca2+ channel downregulation improving muscle force generation in sedentary old mice. Whether TnT3 plays a novel transcription role is still investigated but the authors have suggested that the proteolysis of TnT and the nuclear translocation of fast TnT C-terminal fragment might contribute to the development of age-related sarcopenia [86].
Whilst it is well accepted that the N-terminal variable region of TnT does not contain binding sites for the other components of the troponin complex or for tropomyosin, the significance of its role in the contractile fiber has not been elucidated yet. The questions on the functions of its variability, on the possible interactions with other proteins and/or with divalent cations and on the role of its proteolysis during stress events remain unanswered.
Although no protein has been reported to specifically bind the N-terminal domain of TnT, we have previously demonstrated that the rabbit fast skeletal TnT or its phosphorylated 50-residue N-terminal peptide could restores the allosteric properties of rabbit skeletal muscle AMPD removed by limited proteolysis by trypsin in vitro as well as by a calpain-like proteinase in vivo [11, 12]. Based on our findings we have proposed a model where during strenuous exercise the regulatory site represented by the Zn-binding N-terminal domain of the AMPD1 catalytic subunit is released by calpain and the enzyme shows an unrestrained activity producing large quantities of ammonia. In those conditions, the N-terminal domain of TnT through the Zn ion contained in its putative zinc-binding motif might bind the remaining catalytic Zn ion of the cleaved AMPD1 restoring the allosteric properties of the enzyme through the formation of a vicarious dinuclear Zn metallocenter [13].
Functional characteristics of AMPD isoforms in muscle fibers. The nature of AMPD1 as zinc metalloenzyme
The hydrolytic deamination of AMP to IMP and NH3 is catalysed by AMP deaminase (AMPD), a zinc enzyme that, although is distributed in most animal tissues, shows a particularly elevated activity in skeletal muscle [87].
Extensive work carried out by Parnas and his school well established that ammonia formed by muscle during work arises from the reaction catalyzed by AMPD. Parnas considered irreversible the deamination processing of AMP, which occurs during anaerobic contraction, and hypothesized the existence of a regenerative process of AMP from IMP occurring during periods of oxidative recovery [88].
Parnas ruled out that the ammonia production was directly linked to muscle contraction and proposed that the AMP deamination to IMP was instead the result of the low efficiency of anaerobic glycolysis to convert the AMP produced during muscle contraction into ATP [89]. According to Parnas, the absence of a direct correlation between the NH3 production and muscle contraction was in accord with the observation that NH3 increase was not proportional to the muscle work but it varied based on the duration of the muscle stimulation and on the physiological condition of the animal [90].
During development from fetal to adult muscles, Kendrick-Jones and Perry [91] observed a transition for AMPD similar to that reported for other metabolic enzymes such as adenylate kinase (AK), creatine phosphokinase (CK) and fructose 1,6-diphosphate aldolase, whose activities increase in skeletal muscle development well in accord with the observation that the adult skeletal muscle showed a more highly developed anaerobic metabolism than its fetal counterpart [92].
AMPD is present as multiple isoforms in muscle fibers. Three different AMPD isoforms are sequentially expressed during the development in rat muscles. The embryonal muscles express the AMPD isoform B that is specific of adult non-muscle tissues such as spleen, lung, thymus, blood and liver. Near birth and for the first 2–3 week of life, the perinatal AMPD isoform, corresponding to the heart isoform C, is encoded in the perinatal skeletal muscles together with the adult skeletal muscle AMPD isoform that reaches its maximum expression after 3 weeks of development [93]. Interestingly, as discussed in the above paragraph for the N-terminus of fast skeletal TnT [62], changes in the isoform expression during muscle development, with a timeline similar to the AMPD one, have been reported also for the main contractile proteins, i.e., myosin heavy and light chains, actin, tropomyosin, troponin [93], suggesting that the expression of different isoforms of those proteins may be coordinated during myocyte development.
Three mammalian genes encode for the different muscle isoenzymes, i.e., ampd1, highly expressed in skeletal muscle, and ampd2 and ampd3 that express the smooth and cardiac muscle isoforms, respectively [94]. The N-terminal domains of AMPD1, AMPD2 and AMPD3 isoenzymes are highly divergent while the C-terminal domains are highly conserved. It has also been shown that striated muscle contains two different isoenzymes of AMPD [95,96,97]. The red muscle main form (form A) corresponds chromatographically to the only isoenzyme present in the cardiac muscle (AMPD3), while the minor component found in red muscle (form B) corresponds to the white muscle isoenzyme AMPD1, also called form M [96].
At the optimal pH value 6.5, both isoenzymes show hyperbolic substrate–velocity curves that are reverted to sigmoid by the inhibitory effect of GTP. Form A is almost insensitive to ATP whilst this nucleotide, likewise to GTP, exerts on form B an inhibitory effect. Interestingly, the modulation of the two isoforms differs at pH 7.1 that can be assumed to be the resting fiber pH. At pH 7.1 both enzymes follow sigmoid kinetics, but ATP inhibits form B whilst it stimulates form A, reverting sigmoidal to hyperbolic kinetics shown by the enzyme at optimal pH [97]. The kinetic properties of AMPD isoform M isolated from rabbit skeletal muscles that are mainly composed of white fibers are similar to those of isoform B of red muscle. At physiological concentration of AMP (0.1 mM) isoform M is strongly inhibited by ATP at pH 7.1 whilst ADP modulates the enzyme to follow hyperbolic kinetics even in the presence of ATP. These data could be interpreted as that AMPD is inhibited by ATP during resting or moderate contractile activity of white skeletal muscle, whilst it is activated during strenuous anaerobic contraction, when a decrease in ATP and an increase of ADP levels occur together with the acidification of tissue due to the production of lactate [98].
It is well accepted that the role of AMPD1 is to regulate the relative concentration of adenine nucleotides during muscle contraction: AMPD1 removes AMP from the equilibrium of the AK reaction 2 ADP= ATP + AMP enhancing the production of ATP for the myosin ATPase [13]. The observation that, in contrast with the other AMPD isoforms, including the cardiac one [95], that are activated by ATP, AMPD1 is inhibited by ATP and activated by ADP well supported the hypothesis that the increase in activity of AMPD1 during intense muscular activity is due to the decrease in the ATP/ADP ratio [98].
We reported that the catalytic subunit of rabbit white muscle AMPD1 contains a structurally bridged dinuclear metallocenter [15] composed by the catalytic zinc bound to the C-terminus of the enzyme (corresponding to the single zinc bound at the catalytic site described for murine adenosine deaminase [99] and yeast AMPD [100]) and a zinc bound to the putative zinc-binding site in the N-terminal region. The rabbit histidine-proline-rich-glycoprotein (HPRG) has been reported to be associated with the catalytic subunit of rabbit white skeletal muscle AMPD1 [101] to form a 1:1 molecular adduct (two 85 kDa catalytic subunits assembled with two 73 kDa HPRG subunits) [102,103,104]. When the HPRG component was separated by zinc-affinity chromatography the solubility of the catalytic subunit of the enzyme was markedly reduced [105] strengthening the hypothesis that HPRG functions as a zinc metallochaperone in the formation of the AMPD1 heterotetramer. It was also reported that HPRG is produced only by the liver [106] and that the rabbit skeletal muscle cells internalize the serum protein [107]. Our data have been confirmed by recent in vivo experiments [108] that showed that HPRG, after intravenous injection, was internalized quickly in healthy tissues, including muscle, and tumors.
Functional implications of the presence of a highly differentiated N-terminal region in the AMPD1 catalytic subunit
The removal by trypsin of the 95 amino acids long N-terminal fragment of the rabbit AMPD1 isoform M induces a change in the regulatory properties of the enzyme that becomes more active at low substrate concentration and is no longer inhibited by ATP at optimal pH 6.5 [109,110,111]. Interestingly, a 97 amino acids long N-terminal fragment could be released in vitro from rabbit AMPD1 by a protease with a specificity identical to that reported for ubiquitous calpains [12, 112] and it had been also reported that during storage the human AMPD1 and AMPD3 recombinant isoenzymes were cleaved to mixtures of two polypeptides truncated at the N-terminal region (△I86–△H98 and △L88–△M90, respectively) [113]. All cleavage sites have a Leu at P2, this specifity suggesting that the proteolysis might be mediated by a calpain protease, and that this phenomenon might also occur in vivo playing a role in modulating the AMPD isoenzymes in striated muscle [12]. Interestingly, the N-terminus of rabbit AMPD1 contains a sequence (KELLDA) that is also present in the calpastatin inhibitory domain [114] that might block the access of calpain to its cleavage site during resting or normoxic contractions, thereby protecting against the protease-induced fragmentation of AMPD1 [12]. On the contrary, a strong tetanic contraction in skeletal muscle might induce the activation of a calpain resulting in a large ammonia accumulation due to the increased activity of AMPD that deaminates AMP to IMP.
Our hypothesis that the unrestrained increase in AMPD1 activity upon proteolytic cleavage during strenuous exercise could be reverted by the binding to AMPD1 of the phosphorylated N-terminal region of TnT is supported by our previous data that rabbit fast TnT or its phosphorylated 50-aa residue N-terminal peptide restores in rabbit AMPD1 the inhibition by ATP, removed in vitro by limited proteolysis by trypsin causing the release from the enzyme of a 95 amino acids N-terminal fragment [11]. Since the N-terminal region of fast rabbit TnT contains a putative zinc-binding motif, it could mimic the regulatory action of the AMPD1 N-terminal domain that, when present, forms a dinuclear zinc site with the C-terminal catalytic zinc and maintains the enzyme in its native conformation showing both the positive homotropic behaviour (i.e., activation by the substrate AMP) and the modulation by adenosine di- and triphosphates (i.e., activation by ADP and inhibition by ATP) (Fig. 2).
Our recent study confirmed the presence of a dinuclear zinc site in rabbit AMPD1 showing that the carbethoxylation of His-51 of the Zn2 coordination sphere removes the inhibition by ATP at pH 7.1 through a conformational change of the enzyme C-terminal region, where an ATP-binding site has been localized [115].
Localization of AMPD1 and histidine-proline-rich-glycoprotein (HPRG) in the skeletal muscle fiber
Based on the early observations, AMPD has been found to be associated with various proteins of the contractile machinery [116]. The increase in AMPD activity appeared to be the result of a reversible interaction between AMPD and myofibrils promoted in vivo by intense muscle contraction, suggesting that the role of the enzyme is linked to the maintenance of the adenylate charge under conditions of intense ATP consumption [117,118,119]. Several data on AMPD1 localization in skeletal muscle were obtained by immunostaining of both isolated myofibrils and muscle fibers grown in culture. In unstretched chicken and human muscle myofibrils, AMPD1 staining was located at the lateral ends of the A-band extending into the I-band [120, 121] and could also be found in the center of the A-band, in correspondence to the M-line [120] where other enzymes such as creatine kinase and adenylate kinase have been localized [122]. In agreement with those data, in rabbit fast-twitch muscles the AMPD1 immunostaining was predominantly located in the A-band in a region significantly beyond the end of the myosin filament. It has also been reported that AMPD1 may be attached to the myofibrils through titin molecules, although the interaction of the enzyme with either titin or myosin had no clear influence on its activity [123, 124].
AMPD immunohistochemistry in human skeletal muscle indicated that the three main isoforms are localized in different parts of muscle tissues [120]. AMPD isoform M (AMPD1) was localized predominantly in Type II (fast-twitch) fibers, mainly concentrated subsarcolemmally and intermyofibrillarly and arranged in a cross-striation pattern. Interestingly, AMPD1 was also concentrated at the neuromuscular junctions co-localizing with acetylcholine receptor clusters and in capillary endothelial cells. AMPD isoform L (AMPD2) was localized mainly in myelinated axons and presynaptic areas and, in a moderate concentration, in smooth muscle cells and endothelial cells. No localization was detected in muscle fibers. AMPD isoform E was localized mainly in smooth muscle cells, endothelial cells, and, in a lower concentration, in nerve bundles. In skeletal muscles, AMPD E was detected mainly in Type I (slow-twitch) fibers with a cross-striation pattern similar to AMPD isoform M.
Histidine-proline-rich-glycoprotein (HPRG) is an approximately 70 kDa glycoprotein that has been isolated from the plasma of several mammalian species, but is also found in infant urine, colostrums, milk, platelets, megakaryocites and immune cells such as monocytes and macrophages (reviewed in [125]). HPRG was found to associate with rabbit skeletal muscle AMPD [101]. An investigation by x-ray absorption spectroscopy revealed that the isolated HPRG component of rabbit AMPD1 might contain two Zn ions, coordinated by His and Cys residues [102]. A zinc-binding site that might coordinate the Zn ion with an amino acid arrangement compatible with the histidine-cysteine-containing site of rabbit HPRG appears to be conserved in several mammalian species [103].
Interesting results were found on the localization of HPRG in skeletal muscle. An anti-HPRG antibody selectively marked the type IIB fibers that contain the highest level of AMPD isoform M [126]. Furthermore, a clear correlation between the muscle HPRG content and the level of AMPD activity was obtained from the immunological analyses of human skeletal muscle biopsies from patients with AMPD deficiency [127]. Our immunohistochemical study on human gastrocnemius and quadriceps femoris has localized HPRG preferentially at the I-band level [128]. Interestingly, we also found a nuclear localization of HPRG in the human skeletal muscle, similarly to what was observed with TnT by Zhang et al. [85, 86] that reported that fast-twitching skeletal muscle TnT is fragmented in aging mice and both the full-length TnT and the C-terminal domain of TnT can shuttle to the nucleus and regulate the expression of the voltage sensor Ca2+ channel α1.
The hypothesis that the HPRG-AMPD1 complex might interact with proteins of the thin filament is strengthened by our preliminary data that following the limited tryptic proteolysis of the isolated HPRG component of rabbit AMPD1 actin fragments are released and can be isolated (Ronca and Raggi unpublished observation). The observation that HPRG binds with high-affinity and in a Zn2+ or pH-dependent manner to tropomyosin present on the surface of the FGF-2-activated HUVEC cell [129] strengthens our hypothesis that HPRG acts as a zinc metallochaperone, modulating its intracellular availability for the formation of the dinuclear zinc site critical for AMPD1 stability in its native allosteric conformation [14, 105, 125]. More recently, transmission electron microscopy and immunogold analysis evidenced the presence of HPRG in the sarcomeres, mainly in the I-band. Using the double immunogold staining, a colabeling of HPRG and AMPD1 was evident at sarcomeric, sarcoplasmic reticulum and nuclear levels [130].
Evolution among mammalians of the role of the fast troponin T phosphorylated N-terminus as Zn-binding region in the modulation of skeletal muscle AMP deaminase
To explain the involvement of the N-terminal Zn-binding regions of rabbit fast AMPD and TnT in the modulation of the enzyme activity, we have proposed the model of interaction between the AMPD1 catalytic subunit and the TnT N-terminal domain which is depicted in Fig. 2 (modified from [13]).
The in vivo proteolytic activity of calpain removes the N-terminal domain of AMPD1 with his putative Zn2 binding site involved in the formation of the dinuclear metallocenter, causing the enzyme to show an unrestrained activity that follows hyperbolic kinetics no longer modulated by adenine nucleotides. The interaction of the zinc ion present at the putative zinc-binding site of the TnT N-terminal domain with the catalytic Zn ion (Zn1) of the enzyme might reconstitute the zinc dinuclear center that exists in native AMPD through the interaction of the catalytic Zn1 ion present at the C-terminus of the enzyme with the putative Zn2 ion at the N-terminus at which the competition between activatory (AMP and ADP) and inhibitory (ATP) adenine nucleotides takes place. This model is supported by the experimental observation that the addition in vitro of the phosphorylated N-terminal domain of TnT to AMPD1 proteolyzed by trypsin restored the sigmoid kinetics and the allosteric properties of the native enzyme, i.e., activation by ADP and inhibition by ATP [11].
Whilst the C-terminal region of AMPD1 is thoroughly conserved among vertebrates and always contains the motif SLSTDDP believed to be part of the Zn catalytic center, the N-terminal region differs among the enzyme isoforms.
Data obtained by EXAFS suggested that rabbit skeletal muscle AMPD contains an active site formed by a dinuclear zinc site [14] similarly to other dinuclear zinc hydrolytic enzymes such as dihydroorotase [131] and phosphotriesterase [132]. We provided evidence that the two zinc ions would connect the N-terminal and C-terminal regions of the enzyme being coordinated by 2 histidines and 2 or 3 O ligands (Zn1 and Zn2, respectively) and bridged by a carboxylate and a water/hydroxyde anion. One of the zinc ions (Zn1) is located at the enzyme C-terminus and acts to polarize a nucleophile water molecule, whereas the other (Zn2) is probably bound to the region HHEMQAH (residues 51–57) at the enzyme N-terminus and appears to exert a regulatory role and confer the cooperative behaviour of AMPD1 by transiently binding an activating substrate molecule [15].
Based on our findings of a 309-kDa molecular mass for native rabbit AMPD1 by sedimentation–equilibrium centrifugation [110], we have proposed an AMPD heterotetramer composed of two 85-kDa catalytic subunits assembled with two 70-kDa HPRG subunits [105]. In our opinion, the determination by atomic absorption spectroscopy of 2.6 g atoms of Zn per mole of rabbit AMPD1 [133] is consistent with the presence in the AMPD–HPRG complex of a dinuclear zinc site per AMPD catalytic subunit whose N-terminus was presumably proteolyzed, reducing to 278 kDa the value of the extimated enzyme MW. Further data showed that the rabbit AMPD1 apoenzyme binds 4 g atoms of zinc per mol but the increase of Vmax due to the addition of the fourth zinc atom is only 28% of that expected, suggesting that the fourth zinc atom is not directly associated with the catalytic activity [133].
We have reported that His-51 carbethoxylation by DEP in native rabbit AMPD1 causes a loss of the sensitivity of the enzyme to ATP both at pH 7.1 and at pH 6.5, suggesting that the chemical modification of the Zn2 binding site at the N-terminus of the catalytic subunit of rabbit AMPD1 alters the Zn1 binding coordination and change the conformation of the C-terminal region of the enzyme where an ATP-binding site has been localized [134]. The trypsin-induced removal of the 95-residue N-terminal region of the rabbit enzyme mimics only in part the effect of the carbethoxylation of His-51. We have reported that the trypsinized enzyme at optimal pH 6.5 exhibits hyperbolic kinetics even at low K+ concentration and is no longer inhibited by ATP, but the limited trypsinization does not abolish neither the inhibitory effect by ATP at pH 7.1 nor the pH-dependent stimulation of AMPD1 by substrate [110]. The different effects of carbethoxylation of His-51 and proteolysis of the N-terminal domain of rabbit AMPD1 might be explained with the observation that the proteolysis produces major fragments (residues 24–57, 31–57, 31–72, 36–72), each containing the complete Zn2 binding site, that still could concur to form the dinuclear zinc-binding site.
We have reported that purified rat AMPD1 (MW = 290,000) contains 2 g atoms of zinc per mol of enzyme [135]. Rat AMPD1 has always been isolated as a proteolyzed enzyme retaining the inhibition by ATP at pH 6.5 that in the rabbit AMPD1 is lost following proteolysis. No desensitization towards the nucleotide was obtained even with the limited proteolysis of rat AMPD1 by trypsin carried out following the same protocol used with the rabbit enzyme [111], suggesting that rat and rabbit AMPD1 might differ in their regulatory behaviours.
The comparison among human, rat and rabbit AMPD1 reveals that rabbit His-51, His-52, Glu-53 and His-57, involved in the formation of the putative Zn2 binding site, are conserved in human but not in rat enzyme (Fig. 3), indicating that the divergence in amino acid sequence localized in residues 51–52 (H–H in the rabbit and human enzymes compared to L-R in the rat), might confer different catalytic and regulatory properties to the different AMPD1 isoenzymes and strongly suggests that the dinuclear Zn site might be present in human AMPD1 conferring to it a specific activity and regulation similar to that of the enzyme expressed in the glycolytic muscle fibers of the rabbit. Given the phylogenetic proximity of rabbit to human [136] the complex regulation of rabbit AMPD1 might have been conserved during evolution and might have contributed to the development of specific roles of fast-twitch muscles in the human behaviour.
In a recent review we have extensively described the data that support the hypothesis that HPRG might act as a zinc chaperone for AMPD1 [104]. In addition to the data of colocalization of AMPD1 and HPRG discussed above, HPRG is consistently purified as a complex with rabbit skeletal muscle AMPD1 and the isolation by zinc-affinity chromatography of the HPRG component resulted in the precipitation of the AMPD1 catalytic subunits [105]. Furthermore, a molar ratio HPRG/AMPD minor than 1:1 causes the inactivation of the enzyme at low AMP concentration [105] in line with the dilution-induced homotropic cooperativity in rabbit AMPD1 [137], suggesting a critical role of HPRG in the maintenance of the native quaternary structure of the enzyme. This view is confirmed by the quaternary structure of wild-type human AMPD1 recombinant protein showing that this enzyme exists as a large instable complex (> 2000 kDa) [113]. In our opinion, the behaviour of the recombinant enzyme might result from the aggregation-induced precipitation of the isolated native 85 kDa catalytic subunit.
Although HPRG has been shown to bind to various soft metal ligands and to regulate many biological activities, a likely role as metallochaperone in the formation of AMPD1 heterodimer with skeletal muscle AMPD is well supported by the experimental data that HPRG isolated from rabbit AMPD1 hosts two Zn2+ ions most probably coordinated by His residues and sulfur from cysteine residues [102]. The EXAFS spectrum of the Zn–AMPD–HPRG complexes with various HPRG content demonstrated that no zinc is bound to HPRG when the ternary complex of HPRG with Zn and the AMPD catalytic subunit is formed [14] indicating that HPRG might transfer the metal to the enzyme similarly to what has been documented for the association of superoxide dismutase (SOD1) with its copper chaperone (CCS) that transfers copper to SOD1 probably by forming a temporary intermolecular disulfide bridge [138]. Following the comparison of the HPRG sequence of several placental mammalian species [103], the protein appears to contain, in the so-called PRR1 region, one or two conserved zinc-binding sites formed by at least five amino acid residues known to participate in several soft metal-binding sites (for the rabbit HPRG: Asp-252, His-253, His-257, Cys-264 and Cys-294 that are in agreement with the above mentioned data of the EXAFS analysis of the 2:1 Zn-rabbit HPRG complex). The appearance in the Anthropoidea of a new and highly conserved M-S-C-S/L-S/R-C metal-binding motif, that matches the MxCxxC motif characteristic of metal transporters and metallochaperones, strengthens the hypothesis that HPRG might act as a zinc chaperone of the fast-twitching muscle AMPD1. The high degree of conservation of the HPRG sequences in the Anthropoidea and the conservation of the N-terminal zinc-binding region between rabbit and human AMPD1 might indicate that a functional specialization of the HPRG-AMPD1 tetramer has occurred during evolution that might be associated with the evolution of new white muscle distribution and functions.
Genes that encode the subunits of troponin are found in all invertebrate animals excluding jellyfish and sponges (Cnidaria) and it’s tho
ught to have emerged in parallel with the development of bilateralism and a central nervous system in order to regulate the alternance of muscle contraction and relaxation in coordinated movement of animals [139]. Invertebrate and vertebrate TnT share a conserved core structure and corresponding functions [139]. Similarly to what happens in the vertebrates, several TnT N-terminal variants are generated via alternative RNA splicing of the single invertebrate TnT gene. Interestingly, the TnTs of arthropods and some flying insects such as Lethocerus and Drosophila, have an extended C-terminus containing 49 glutamic acid residues of unknown function [140,141,142]. With the hypothesis that the C-terminus Glu-rich domain of Drosophila TnT might have a role as a Ca2+ buffer/reservoir, mutant flies expressing a C-terminus deletion of TnT have been tested in various muscle exercises. Although the C-terminal deleted TnT maintained its core functions in muscle contraction, the mutant flies had decreased capabilities in both acute and chronic muscle activities, such as climbing velocity, acute flight performance and endurance. Furthermore, the observation that the mutant fly hearts were more resistant to acute Ca2+ overloading produced by the electrical pacing–induced membrane depolarization of cardiomyocytes supported the hypothesis that removal of the long Glu-rich C-terminal extension of Drosophila TnT diminishes the Ca2+ buffering capacity in the myofilaments by lowering the baseline content of Ca2+ and allowing the cardiac muscle to better tolerate acute Ca2+ overloading [143]. Before these studies in Drosophila, a similar role as a Ca2+ buffer/reservoir has been previously proposed for the His and Glu-rich N-terminal domain of the avian pectoral muscle fast TnT expressed in Galliformes and Craciformes [73]. The adult chicken breast muscle TnT was found to bind multiple calcium ions per protein molecule in a non-saturable fashion with affinity in the micromolar range. The atomic model simulations with varying numbers of calcium and zinc ions predicted that both calcium and zinc ions could bind with high-affinity to the N-terminal chicken breast muscle TnT but, consistently with previous data discussed below, only the binding of Zn2+ changed the protein conformation. The physiological role of TnT in avian pectoralis muscle could be that of binding Ca2+ toward the end of a calcium wave, reducing therefore the twitch length and giving the advantage of a faster contraction cycle in avian flight muscles.
It should be noted, however, that the sequences of the drosophila and chicken cation binding segments differ considerably in amino acid composition, charge and position in the TnT protein: the N-terminal domain of avian fast TnT contains 18 His residues and 24 Glu residues over a 80-aa fragment (1MSDTEEVEHGEAHEAEEVHEEAHHEEAHHEEAHHEEAHHAEAHHAEAHHEEAHAHAEEVHEPAPPPEEKPRIKLTAPKIP80) whereas the C-terminal domain found in Drosophila contains 50 Glu residues and no His residues over a fragment with the same length (nWFGERPGKKAGEPETPEGEEDAKADEDIVEDDEEVEEEVVEEEDEEAEEDEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEm). In the avian sequence the His and Glu residues are arranged as a seven-repeated sequence HE/AEAH, designated Tx, that closely resemble a binding site for transition metal ions and has been demonstrated to have high-affinity for Cu2+ > Ni2+ > Zn2+ ≈ Co2+ [65]. Similar zinc-binding sequences HEXXH and HEXXXH have been described in various zinc peptidases [144, 145]. Experimentally, it has been demonstrated that both the N-terminus and the full-length chicken breast muscle TnT could be purified by Zn2+ affinity chromatography, whereas they were not retained on the Mg2+, Ca2+, Mn2+ or Fe2+ columns [65, 73]. Furthermore, the binding of Zn2+ to the N-terminal region of chicken breast muscle TnT changed the conformation of the protein and its binding to Tm, TnI, and TnC [146]. In contrast, addition of Zn2+ ions had no significant effect on the interaction with Tm of the chicken leg muscle TnT3 isoform that does not contain the Tx sequence [75].
In consideration of the above-described discrepancies of the literature, it would be interesting to investigate whether Zn2+ has higher affinity than Ca2+ for the N-terminal region of chicken breast muscle TnT and would displace the Ca ion(s) bound to the protein. In addition, it would be worthy to study whether the ability to bind one specific divalent cation is affected by the phosphorylation status of Ser1 since we have demonstrated that the phosphorylated 50-residue N-terminal peptide of rabbit fast skeletal TnT restores the allosteric properties of rabbit skeletal muscle AMPD removed by limited proteolysis by trypsin in vitro as well as by a calpain-like proteinase in vivo. Treatment of the peptide with alkaline phosphatase abolishes the modulating properties of the peptide, suggesting that phosphorylation-dephosphorylation processes might be involved in the regulation of the enzyme [11, 12].
The functional significance of the presence of multiple metal-binding sites in the TnT isoform expressed in the fast glycolytic fibers of the pectoralis muscles of Galliformes and Craciformes is not clear yet. It has been suggested that the binding of metal ions to the variable N-terminal region of the Tx-positive TnT isoforms might modify the function of TnT in muscle contraction and could be regarded as an evolutionary adaptation that brought to the development of their rapid burst fly pattern [65]. However, the presence of fast TnT isoforms containing one or two putative Zn-binding sites within the N-terminal region can be detected in many other birds in agreement with previous data that Tx-positive TnT proteins could be also detected by a monoclonal antibody raised against chicken Tx-containing native TnT in the white muscle of several avian species [63]. With increasing depositions of new animal sequences in the NCBI database, the same Zn-binding motif can be found in few of the fast TnT isoforms of jawless fish, cartilaginous fish, bony fish, amphibians and reptiles, suggesting that the putative zinc-binding motif might have appeared early in the evolution of Cordata, whereas, based on the sequences available to date, the putative Zn-binding site of AMPD1 is restricted to the Primata and to the phylogenetically close rabbit. Further studies are needed to determine whether the acquisition of a dinuclear zinc-binding site in AMPD1 in higher Mammalia and the ability to interact with the TnT N-terminal region has a significance in the development of an advanced way to regulate the muscle contraction.
Conclusions
We report in this review several correlations between AMPD and TnT worth noting. In higher vertebrates three AMPD isoenzymes are differentially expressed in fast skeletal, slow skeletal, and cardiac muscle fibers. Similarly, three homologous TnT genes encode for various TnT isoforms that differ mainly in muscle type expression, length, and charge of the N-terminal region, while the central and C-terminal regions are highly conserved [7]. The ability of the TnT variable N-terminal region to interact with zinc and with other muscle fiber proteins could be at the base of a wide range of physiological responses of different muscle fibers, allowing a rapid and fine-tuned adaptation to the changes in contractile demands.
As seen for the AMPD1 isoforms, cardiac and skeletal muscle TnT are proteolyzed in vivo by calpains. During physiological and pathological adaptation of cardiac muscle, such as ischemia–reperfusion and pressure overload, a restricted proteolysis of cardiac TnT by m-calpain occurs that results in the selective removal of the 71 aa N-terminal variable domain not only altering the binding affinities for Tm, TnC and TnI but also lowering the myosin ATPase activity and contractile force generation [80, 81].
Similarly to the cardiac muscle, physio-pathological changes in skeletal muscle induce a compensatory switch for both TnT and AMPD isoforms. In various neuromuscular diseases or after sciatic nerve denervation, the cardiac isoform of TnT, expressed in skeletal muscles only during the fibers development, is up-regulated in the adult fibers [147]. In rodent skeletal muscle atrophy characterized by a preferential loss of fast-twitch fibers, the expression of many enzymes involved in ATP production and glycolysis is down-regulated, whereas other enzymes, including AMPD3 are markedly up-regulated [148]. Furthermore, following denervation of rat skeletal muscle, the total AMPD activity increased by 34% due to the increase in AMPD3 expression that resulted in a change of the AMPD1/AMPD3 subunit ratio in the composition of the holoenzyme [149].
Parnas and Lewinski [90] reported that the amount of NH3 developed from frog muscles was not proportional to the amount of muscle work executed since in muscles performing a similar number of contractions the ammonia production increased in the months of activity from January till June but decreased in the months leading to hibernation (November). Taking into account what was observed in the heart of toad where the slow TnT1 isoform replaces cardiac TnT2, suggesting a physiological value to this evolutionary adaptation by which the toad heart is able more than the frog heart to cope with the decrease of blood volume that occurs during dry season, it would be interesting to determine whether the increase in NH3 production is linked to the expression of different isoforms of AMPD or the regulation of the AMPD activity changes as a physiological adaptation to obtain a higher capacity of fast contractions required for example for jumping.
The above-described similarities between TnT and AMPD such as the isoform switch during muscle development, the adaptation to different contractile necessities or the readjusting to the change of environmental conditions, the restricted proteolysis by calpains of the N-terminal domains containing both a putative zinc-binding site and the nuclear localization shared by the two proteins, altogether suggest a distinctive relationship between TnT and AMPD. The ability of the TnT variable N-terminal region to interact through a zinc bridge with the enzyme catalyzing the deamination of AMP to maintain a high energy charge and supply myosin ATPase with ATP could be at the base of a rapid and fine-tuned adaptation to the changes in contractile demands.
In this context also deserves consideration the observation that in muscle the cytoplasmic free zinc concentration is very low (about 10–10 M) [150] suggesting that the presence of intracellular Zn-chaperones could be critical for the physiological functions of a Zn metalloenzyme such as AMPD and sarcomeric proteins that have zinc-binding sites such as TnT. This is particularly true for the zinc-binding protein HPRG that we have shown to be candidate to provide the zinc ions to stabilize the AMPD1 native conformation.
The zinc dinuclear center present in rabbit fast-twitch AMPD1 could have a regulatory role in holding the enzyme in a less active conformation during muscle contractions under normoxic conditions. However, during strenuous exercise and to the greatest extent during rigor mortis [151], the unrestrained AMPD1 activity caused by the calpain-dependent cleavage of the enzyme N-terminus is responsible for the large ammonia production [12, 13]. Interestingly, based on the comparison of the amino acid sequences, the zinc dinuclear center, formed by the regulatory N-terminal domain and the catalytic C-terminal domain, is probably present in human AMPD1 as well as in the rabbit enzyme but not in rat AMPD1, suggesting that the pH-dependent complex regulation of AMPD1 linked to such structure might have a specific function in human fast skeletal muscle fibers IIA and IIB that have higher shortening velocity but are generally prone to fatigue [152]. In human, the fast-like type II muscle fibers predominate in the hands and in several cutaneous facial (mimetic) muscles, in the tongue and in the larynx (reviewed in [115]). During human evolution, the finger fine movements and the coordination of muscles involved in blinking, mastication, sucking and emitting sounds certainly required a very precise and complex regulation and the fine synergy between slow and fast muscle fibers might have contributed to the development of hand dexterity, thumb prehension, emotional expression and phonation.
Data availability
Data supporting this study are included within the article and/or supporting materials.
Reference
Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80:853–924. https://doi.org/10.1152/physrev.2000.80.2.853
Perry SV (1998) Troponin T: genetics, properties and function. J Muscle Res Cell Motil 19:575–602. https://doi.org/10.1023/a:1005397501968
Gomes AV, Potter JD, Szczesna-Cordary D (2002) The role of troponins in muscle contraction. IUBMB Life 54:323–333. https://doi.org/10.1080/15216540216037
Medford RM, Nguyen HT, Destree AT, Summers E, Nadal-Ginard B (1984) A novel mechanism of alternative RNA splicing for the developmentally regulated generation of troponin T isoforms from a single gene. Cell 38:409–421. https://doi.org/10.1016/0092-8674(84)90496-3
Breitbart RE, Nguyen HT, Medford RM, Destree AT, Mahdavi V, Nadal-Ginard B (1985) Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene. Cell 41:67–82. https://doi.org/10.1016/0092-8674(85)90062-5
Jin JP, Huang QQ, Yeh HI, Lin JJ (1992) Complete nucleotide sequence and structural organization of rat cardiac troponin T gene. A single gene generates embryonic and adult isoforms via developmentally regulated alternative splicing. J Mol Biol 227:1269–1276. https://doi.org/10.1016/0022-2836(92)90540-z
Jin JP (2016) Evolution, regulation, and function of N-terminal variable region of troponin T: modulation of muscle contractility and beyond. Int Rev Cell Mol Biol 321:1–28. https://doi.org/10.1016/bs.ircmb.2015.09.002
Amarasinghe C, Jin JP (2015) N-terminal hypervariable region of muscle type isoforms of troponin T differentially modulates the affinity of tropomyosin-binding site 1. Biochemistry 54:3822–3830. https://doi.org/10.1021/acs.biochem.5b00348
Gomes AV, Venkatraman G, Davis JP, Tikunova SB, Engel P, Solaro RJ, Potter JD (2004) Cardiac troponin T isoforms affect the Ca(2+) sensitivity of force development in the presence of slow skeletal troponin I: insights into the role of troponin T isoforms in the fetal heart. J Biol Chem 279:49579–49587. https://doi.org/10.1074/jbc.M407340200
Malnic B, Farah CS, Reinach FC (1998) Regulatory properties of the NH2- and COOH-terminal domains of troponin T. ATPase activation and binding to troponin I and troponin C. J Biol Chem 273:10594–10601. https://doi.org/10.1074/jbc.273.17.10594
Ranieri-Raggi M, Moir AJ, Raggi A (1985) Interaction with troponin T from white skeletal muscle restores in white skeletal muscle AMP deaminase those allosteric properties removed by limited proteolysis. Biochim Biophys Acta 827:93–100. https://doi.org/10.1016/0167-4838(85)90104-9
Martini D, Montali U, Ranieri-Raggi M, Sabbatini AR, Thorpe SJ, Moir AJ, Raggi A (2004) A calpain-like proteolytic activity produces the limited cleavage at the N-terminal regulatory domain of rabbit skeletal muscle AMP deaminase: evidence of a protective molecular mechanism. Biochim Biophys Acta 1702:191–198. https://doi.org/10.1016/j.bbapap.2004.08.014
Ronca F, Raggi A (2017) Role of troponin T and AMP deaminase in the modulation of skeletal muscle contraction. Rend Fis Acc Lincei 28:143–158
Mangani S, Benvenuti M, Moir AJ, Ranieri-Raggi M, Martini D, Sabbatini AR, Raggi A (2007) Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site. Biochim Biophys Acta 1774:312–322. https://doi.org/10.1016/j.bbapap.2006.12.005
Martini D, Ranieri-Raggi M, Sabbatini AR, Moir AJ, Polizzi E, Mangani S, Raggi A (2007) Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. A new model for substrate interactions at a dinuclear cocatalytic Zn site. Biochim Biophys Acta 1774(12):1508–1518. https://doi.org/10.1016/j.bbapap.2007.10.004
Perry SV (1999) Troponin I: inhibitor or facilitator. Mol Cell Biochem 190:9–32
Amphlett GW, Vanaman TC, Perry SV (1976) Effect of the troponin C-like protein from bovine brain (brain modulator protein) on the Mg2+-stimulated ATPase of skeletal muscle actinomyosin. FEBS Lett 72:163–168. https://doi.org/10.1016/0014-5793(76)80836-8
Potter JD, Sheng Z, Pan BS, Zhao J (1995) A direct regulatory role for troponin T and a dual role for troponin C in the Ca2+ regulation of muscle contraction. J Biol Chem 270:2557–2562. https://doi.org/10.1074/jbc.270.6.2557
Ohtsuki I (1979) Molecular arrangement of troponin-T in the thin filament. J Biochem 86:491–497. https://doi.org/10.1093/oxfordjournals.jbchem.a132549
Jin JP, Chong SM (2010) Localization of the two tropomyosin-binding sites of troponin T. Arch Biochem Biophys 500:144–150. https://doi.org/10.1016/j.abb.2010.06.001
Jackson P, Amphlett GW, Perry SV (1975) The primary structure of troponin T and the interaction with tropomyosin. Biochem J 151:85–97. https://doi.org/10.1042/bj1510085
Pearlstone JR, Carpenter MR, Smillie LB (1977) Primary structure of rabbit skeletal muscle troponin-T. Purification of cyanogen bromide fragments and the amino acid sequence of fragment CB2. J Biol Chem 252:971–977
Takeda S, Yamashita A, Maeda K, Maeda Y (2003) Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 424:35–41. https://doi.org/10.1038/nature01780
Vinogradova MV, Stone DB, Malanina GG, Karatzaferi C, Cooke R, Mendelson RA, Fletterick RJ (2005) Ca(2+)-regulated structural changes in troponin. Proc Natl Acad Sci USA 102:5038–5043. https://doi.org/10.1073/pnas.0408882102
Moir AJ, Cole HA, Perry SV (1977) The phosphorylation sites of troponin T from white skeletal muscle and the effects of interaction with troponin C on their phosphorylation by phosphorylase kinase. Biochem J 161:371–382. https://doi.org/10.1042/bj1610371
Dobroval’skiĭ AB, Gusev NB, Martinov AV, Severin SE (1976) Search for a protein kinase specific for troponin T. Biokhimiya 41:1291–1296
Wei B, Jin JP (2011) Troponin T isoforms and posttranscriptional modifications: evolution, regulation and function. Arch Biochem Biophys 505:144–154. https://doi.org/10.1016/j.abb.2010.10.013
Heeley DH, Golosinska K, Smillie LB (1987) The effects of troponin T fragments T1 and T2 on the binding of nonpolymerizable tropomyosin to F-actin in the presence and absence of troponin I and troponin C. J Biol Chem 262:9971–9978
Pearlstone JR, Smillie LB (1982) Binding of troponin-T fragments to several types of tropomyosin. Sensitivity to Ca2+ in the presence of troponin-C. J Biol Chem 257:10587–10592
Ohtsuki I, Shiraishi F, Suenaga N, Miyata T, Tanokura M (1984) A 26K fragment of troponin T from rabbit skeletal muscle. J Biochem 95:1337–1342. https://doi.org/10.1093/oxfordjournals.jbchem.a134740
Tobacman LS (1988) Structure-function studies of the amino-terminal region of bovine cardiac troponin T. J Biol Chem 263:2668–2672
Pearlstone JR, Smillie LB (1978) Troponin T fragments: physical properties and binding to troponin C. Can J Biochem 56:521–527. https://doi.org/10.1139/o78-080
Tanokura M, Tawada Y, Ono A, Ohtsuki I (1983) Chymotryptic subfragments of troponin T from rabbit skeletal muscle. Interaction with tropomyosin, troponin I and troponin C. J Biochem 93:331–337. https://doi.org/10.1093/oxfordjournals.jbchem.a134185
Raggi A, Grand RJ, Moir AJ, Perry SV (1989) Structure-function relationships in cardiac troponin T. Biochim Biophys Acta 997:135–143. https://doi.org/10.1016/0167-4838(89)90145-3
Biesiadecki BJ, Chong SM, Nosek TM, Jin JP (2007) Troponin T core structure and the regulatory NH2-terminal variable region. Biochemistry 46:1368–1379. https://doi.org/10.1021/bi061949m
Breitbart RE, Nadal-Ginard B (1986) Complete nucleotide sequence of the fast skeletal troponin T gene. Alternatively spliced exons exhibit unusual interspecies divergence. J Mol Biol 188:313–324. https://doi.org/10.1016/0022-2836(86)90157-9
Cooper TA, Ordahl CP (1985) A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J Biol Chem 260:11140–11148
Farza H, Townsend PJ, Carrier L, Barton PJ, Mesnard L, Bährend E, Forissier JF, Fiszman M, Yacoub MH, Schwartz K (1998) Genomic organisation, alternative splicing and polymorphisms of the human cardiac troponin T gene. J Mol Cell Cardiol 30:1247–1253. https://doi.org/10.1006/jmcc.1998.0698
Hirao C, Yonemura I, Miyazaki J (2004) Genomic structure of the chicken slow skeletal muscle troponin T gene. Gene 338:243–256. https://doi.org/10.1016/j.gene.2004.05.023
Huang QQ, Chen A, Jin JP (1999) Genomic sequence and structural organization of mouse slow skeletal muscle troponin T gene. Gene 229:1–10. https://doi.org/10.1016/s0378-1119(99)00051-7
Chong SM, Jin JP (2009) To investigate protein evolution by detecting suppressed epitope structures. J Mol Evol 68:448–460. https://doi.org/10.1007/s00239-009-9202-0
Jin JP, Zhang Z, Bautista JA (2008) Isoform diversity, regulation, and functional adaptation of troponin and calponin. Crit Rev Eukaryot Gene Expr 18:93–124. https://doi.org/10.1615/critreveukargeneexpr.v18.i2.10
Sheng JJ, Jin JP (2014) Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused review. Front Physiol 5:165. https://doi.org/10.3389/fphys.2014.00165
Jin JP, Chen A, Huang QQ (1998) Three alternatively spliced mouse slow skeletal muscle troponin T isoforms: conserved primary structure and regulated expression during postnatal development. Gene 214:121–129. https://doi.org/10.1016/s0378-1119(98)00214-5
Feng HZ, Chen X, Hossain MM, Jin JP (2012) Toad heart utilizes exclusively slow skeletal muscle troponin T: an evolutionary adaptation with potential functional benefits. J Biol Chem 287:29753–29764. https://doi.org/10.1074/jbc.M112.373191
Biesiadecki BJ, Jin JP (2002) Exon skipping in cardiac troponin T of turkeys with inherited dilated cardiomyopathy. J Biol Chem 277:18459–18468. https://doi.org/10.1074/jbc.M200788200
Biesiadecki BJ, Elder BD, Yu ZB, Jin JP (2002) Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy. J Biol Chem 277:50275–50285. https://doi.org/10.1074/jbc.M206369200
Anderson PA, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK (1995) Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 76:681–686. https://doi.org/10.1161/01.res.76.4.681
Mesnard-Rouiller L, Mercadier JJ, Butler-Browne G, Heimburger M, Logeart D, Allen PD, Samson F (1997) Troponin T mRNA and protein isoforms in the human left ventricle: pattern of expression in failing and control hearts. J Mol Cell Cardiol 29:3043–3055. https://doi.org/10.1006/jmcc.1997.0519
Akella AB, Ding XL, Cheng R, Gulati J (1995) Diminished Ca2+ sensitivity of skinned cardiac muscle contractility coincident with troponin T-band shifts in the diabetic rat. Circ Res 76:600–606. https://doi.org/10.1161/01.res.76.4.600
McConnell BK, Moravec CS, Bond M (1998) Troponin I phosphorylation and myofilament calcium sensitivity during decompensated cardiac hypertrophy. Am J Physiol 274:H385–H396. https://doi.org/10.1152/ajpheart.1998.274.2.H385
Hasenfuss G (1998) Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39:60–76. https://doi.org/10.1016/s0008-6363(98)00110-2
Tilley LP, Liu SK, Gilbertson SR, Wagner BM, Lord PF (1977) Primary myocardial disease in the cat. A model for human cardiomyopathy. Am J Pathol 86:493–522
Jin JP, Brotto MA, Hossain MM, Huang QQ, Brotto LS, Nosek TM, Morton DH, Crawford TO (2003) Truncation by Glu180 nonsense mutation results in complete loss of slow skeletal muscle troponin T in a lethal nemaline myopathy. J Biol Chem 278:26159–26165. https://doi.org/10.1074/jbc.M303469200
Johnston JJ, Kelley RI, Crawford TO, Morton DH, Agarwala R, Koch T, Schäffer AA, Francomano CA, Biesecker LG (2000) A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 67:814–821. https://doi.org/10.1086/303089
Feng HZ, Wei B, Jin JP (2009) Deletion of a genomic segment containing the cardiac troponin I gene knocks down expression of the slow troponin T gene and impairs fatigue tolerance of diaphragm muscle. J Biol Chem 284:31798–31806. https://doi.org/10.1074/jbc.M109.020826
Fox MD, Carson VJ, Feng HZ, Lawlor MW, Gray JT, Brigatti KW, Jin JP, Strauss KA (2018) TNNT1 nemaline myopathy: natural history and therapeutic frontier. Hum Mol Genet 27:3272–3282. https://doi.org/10.1093/hmg/ddy233
Sandaradura SA, Bournazos A, Mallawaarachchi A, Cummings BB, Waddell LB, Jones KJ, Troedson C, Sudarsanam A, Nash BM, Peters GB, Algar EM, MacArthur DG, North KN, Brammah S, Charlton A, Laing NG, Wilson MJ, Davis MR, Cooper ST (2018) Nemaline myopathy and distal arthrogryposis associated with an autosomal recessive TNNT3 splice variant. Hum Mutat 39:383–388. https://doi.org/10.1002/humu.23385
Calame DG, Fatih J, Herman I, Akdemir ZC, Du H, Jhangiani SN, Gibbs RA, Marafi D, Pehlivan D, Posey JE, Lotze T, Mancias P, Bhattacharjee MB, Lupski JR (2021) Biallelic pathogenic variants in TNNT3 associated with congenital myopathy. Neurol Genet. https://doi.org/10.1212/NXG.0000000000000589
Ogut O, Jin JP (1998) Developmentally regulated, alternative RNA splicing-generated pectoral muscle-specific troponin T isoforms and role of the NH2-terminal hypervariable region in the tolerance to acidosis. J Biol Chem 273:27858–27866. https://doi.org/10.1074/jbc.273.43.27858
Smillie LB, Golosinska K, Reinach FC (1988) Sequences of complete cDNAs encoding four variants of chicken skeletal muscle troponin T. J Biol Chem 263:18816–18820
Wang J, Jin JP (1997) Primary structure and developmental acidic to basic transition of 13 alternatively spliced mouse fast skeletal muscle troponin T isoforms. Gene 193:105–114. https://doi.org/10.1016/s0378-1119(97)00100-5
Jin JP, Samanez RA (2001) Evolution of a metal-binding cluster in the NH(2)-terminal variable region of avian fast skeletal muscle troponin T: functional divergence on the basis of tolerance to structural drifting. J Mol Evol 52:103–116. https://doi.org/10.1007/s002390010139
Miyazaki J, Jozaki M, Nakatani N, Watanabe T, Saba R, Nakada K, Hirabayashi T, Yonemura I (1999) The structure of the avian fast skeletal muscle troponin T gene: seven novel tandem-arranged exons in the exon x region. J Muscle Res Cell Motil 20:655–660. https://doi.org/10.1023/a:1005504018059
Jin JP, Smillie LB (1994) An unusual metal-binding cluster found exclusively in the avian breast muscle troponin T of Galliformes and Craciformes. FEBS Lett 341:135–140. https://doi.org/10.1016/0014-5793(94)80256-4
Gahlmann R, Troutt AB, Wade RP, Gunning P, Kedes L (1987) Alternative splicing generates variants in important functional domains of human slow skeletal troponin T. J Biol Chem 262:16122–16126
Ogut O, Granzier H, Jin JP (1999) Acidic and basic troponin T isoforms in mature fast-twitch skeletal muscle and effect on contractility. Am J Physiol 276:C1162–C1170. https://doi.org/10.1152/ajpcell.1999.276.5.C1162
Reiser PJ, Greaser ML, Moss RL (1992) Developmental changes in troponin T isoform expression and tension production in chicken single skeletal muscle fibres. J Physiol 449:573–588. https://doi.org/10.1113/jphysiol.1992.sp019102
Reiser PJ, Greaser ML, Moss RL (1996) Contractile properties and protein isoforms of single fibres from the chicken pectoralis red strip muscle. J Physiol 493:553–562. https://doi.org/10.1113/jphysiol.1996.sp021403
Solaro RJ, Lee JA, Kentish JC, Allen DG (1988) Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ Res 63:779–787. https://doi.org/10.1161/01.res.63.4.779
Nosek TM, Brotto MA, Jin JP (2004) Troponin T isoforms alter the tolerance of transgenic mouse cardiac muscle to acidosis. Arch Biochem Biophys 430:178–184. https://doi.org/10.1016/j.abb.2004.07.014
Jin JP, Wang J, Zhang J (1996) Expression of cDNAs encoding mouse cardiac troponin T isoforms: characterization of a large sample of independent clones. Gene 168:217–221. https://doi.org/10.1016/0378-1119(95)00803-9
Zhang Z, Jin JP, Root DD (2004) Binding of calcium ions to an avian flight muscle troponin T. Biochemistry 43:2645–2655. https://doi.org/10.1021/bi035067o
Jin JP, Root DD (2000) Modulation of troponin T molecular conformation and flexibility by metal ion binding to the NH2-terminal variable region. Biochemistry 39:11702–11713. https://doi.org/10.1021/bi9927437
Ogut O, Jin JP (1996) Expression, zinc-affinity purification, and characterization of a novel metal-binding cluster in troponin T: metal-stabilized alpha-helical structure and effects of the NH2-terminal variable region on the conformation of intact troponin T and its association with tropomyosin. Biochemistry 35:16581–16590. https://doi.org/10.1021/bi961712y
Bucher EA, Dhoot GK, Emerson MM, Ober M, Emerson CP Jr (1999) Structure and evolution of the alternatively spliced fast troponin T isoform gene. J Biol Chem 274:17661–17670. https://doi.org/10.1074/jbc.274.25.17661
Marston SB, Walker JW (2009) Back to the future: new techniques show that forgotten phosphorylation sites are present in contractile proteins of the heart whilst intensively studied sites appear to be absent. J Muscle Res Cell Motil 30:93–95. https://doi.org/10.1007/s10974-009-9184-y
Sancho Solis R, Ge Y, Walker JW (2008) Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry. J Muscle Res Cell Motil 29:203–212. https://doi.org/10.1007/s10974-009-9168-y
Zhang Z, Feng HZ, Jin JP (2011) Structure of the NH2-terminal variable region of cardiac troponin T determines its sensitivity to restrictive cleavage in pathophysiological adaptation. Arch Biochem Biophys 515:37–45. https://doi.org/10.1016/j.abb.2011.08.013
Zhang Z, Biesiadecki BJ, Jin JP (2006) Selective deletion of the NH2-terminal variable region of cardiac troponin T in ischemia reperfusion by myofibril-associated mu-calpain cleavage. Biochemistry 45:11681–11694. https://doi.org/10.1021/bi060273s
Feng HZ, Biesiadecki BJ, Yu ZB, Hossain MM, Jin JP (2008) Restricted N-terminal truncation of cardiac troponin T: a novel mechanism for functional adaptation to energetic crisis. J Physiol 586:3537–3550. https://doi.org/10.1113/jphysiol.2008.153577
Chandra M, Montgomery DE, Kim JJ, Solaro RJ (1999) The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments. J Mol Cell Cardiol 31:867–880. https://doi.org/10.1006/jmcc.1999.0928
Fujita S, Maeda K, Maeda Y (1992) Expression in Escherichia coli and a functional study of a beta-troponin T 25 kDa fragment of rabbit skeletal muscle. J Biochem 112:306–308. https://doi.org/10.1093/oxfordjournals.jbchem.a123896
Pan BS, Gordon AM, Potter JD (1991) Deletion of the first 45 NH2-terminal residues of rabbit skeletal troponin T strengthens binding of troponin to immobilized tropomyosin. J Biol Chem 266:12432–12438
Zhang T, Taylor J, Jiang Y, Pereyra AS, Messi ML, Wang ZM, Hereñú C, Delbono O (2015) Troponin T3 regulates nuclear localization of the calcium channel Cavβ1a subunit in skeletal muscle. Exp Cell Res 336:276–286. https://doi.org/10.1016/j.yexcr.2015.05.005
Zhang T, Pereyra AS, Wang ZM, Birbrair A, Reisz JA, Files DC, Purcell L, Feng X, Messi ML, Feng H, Chalovich J, Jin JP, Furdui C, Delbono O (2016) Calpain inhibition rescues troponin T3 fragmentation, increases Cav1.1, and enhances skeletal muscle force in aging sedentary mice. Aging Cell 15:488–498. https://doi.org/10.1111/acel.12453
Conway EJ, Cooke R (1939) The deaminases of adenosine and adenylic acid in blood and tissues. Biochem J 33:479–492. https://doi.org/10.1042/bj0330479
Parnas JK (1929) Über die Ammoniakbildung im Muskel und ihren Zusammenhang mit Funktion und Zustandsänderung. Der Zusammenhang der Ammoniakbildung mit der Umwandlung des Adeninnucleotids zu Inosinsäure. Biochem Z 206:16–38
Parnas JK, Lewinski W, Jaworska J, Umschweif B (1930) Über den Ammoniakgehalt und die Ammoniakbildung im Froschmuskel. Biochem Z 228:366–400
Parnas JK, Lewinski W (1935) Über den Zusammenhang zwischen Ammoniakbildung und Muskeltätigkeit unter aeroben Bedingungen. Biochem Z 276:398–407
Kendrick-Jones J, Perry SV (1967) The enzymes of adenine nucleotide metabolism in developing skeletal muscle. Biochem J 103:207–214. https://doi.org/10.1042/bj1030207
Hartshorne DJ, Perry SV (1962) A chromatographic and electrophoretic study of sarcoplasm from adult-and foetal-rabbit muscles. Biochem J 85:171–177. https://doi.org/10.1042/bj0850171
Marquetant R, Desai NM, Sabina RL, Holmes EW (1987) Evidence for sequential expression of multiple AMP deaminase isoforms during skeletal muscle development. Proc Natl Acad Sci USA 84:2345–2349. https://doi.org/10.1073/pnas.84.8.2345
Sabina RL, Morisaki T, Clarke P, Eddy R, Shows TB, Morton CC, Holmes EW (1990) Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem 265:9423–9433. https://doi.org/10.1016/S0021-9258(19)38866-0
Barsacchi R, Ranieri-Raggi M, Bergamini C, Raggi A (1979) Adenylate metabolism in the heart. Regulatory properties of rabbit cardiac adenylate deaminase. Biochem J 182:361–366. https://doi.org/10.1042/bj1820361
Raggi A, Bergamini C, Ronca G (1975) Isozymes of AMP deaminase in red and white skeletal muscles. FEBS Lett 58:19–23. https://doi.org/10.1016/0014-5793(75)80216-x
Raggi A, Ranieri-Raggi M (1987) Regulatory properties of AMP deaminase isoenzymes from rabbit red muscle. Biochem J 242:875–879. https://doi.org/10.1042/bj2420875
Ronca-Testoni S, Raggi A, Ronca G (1970) Muscle AMP aminohydrolase. 3. A comparative study on the regulatory properties of skeletal muscle enzyme from various species. Biochim Biophys Acta 1(98):101–112. https://doi.org/10.1016/0005-2744(70)90038-0
Wilson DK, Rudolph FB, Quiocho FA (1991) Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science 252:1278–1284. https://doi.org/10.1126/science.1925539
Merkler DJ, Schramm VL (1993) Catalytic mechanism of yeast adenosine 5’-monophosphate deaminase. Zinc content, substrate specificity, pH studies and solvent isotope effects. Biochemistry 32:5792–5799. https://doi.org/10.1021/bi00073a011
Ranieri-Raggi M, Montali U, Ronca F, Sabbatini A, Brown PE, Moir AJ, Raggi A (1997) Association of purified skeletal-muscle AMP deaminase with a histidine-proline-rich-glycoprotein-like molecule. Biochem J 326:641–648. https://doi.org/10.1042/bj3260641
Mangani S, Meyer-Klaucke W, Moir AJ, Ranieri-Raggi M, Martini D, Raggi A (2003) Characterization of the zinc-binding site of the histidine-proline-rich glycoprotein associated with rabbit skeletal muscle AMP deaminase. J Biol Chem 278:3176–3184. https://doi.org/10.1074/jbc.M208794200
Ronca F, Raggi A (2015) Structure-function relationships in mammalian histidine-proline-rich glycoprotein. Biochimie 118:207–220. https://doi.org/10.1016/j.biochi.2015.09.024
Ronca F, Raggi A (2018) Role of the HPRG component of striated muscle AMP deaminase in the stability and cellular behaviour of the enzyme. Biomolecules 8:79–100. https://doi.org/10.3390/biom8030079
Ranieri-Raggi M, Martini D, Sabbatini AR, Moir AJ, Raggi A (2003) Isolation by zinc-affinity chromatography of the histidine-proline-rich-glycoprotein molecule associated with rabbit skeletal muscle AMP deaminase. Evidence that the formation of a protein-protein complex between the catalytic subunit and the novel component is critical for the stability of the enzyme. Biochim Biophys Acta 1645:81–88. https://doi.org/10.1016/s1570-9639(02)00527-7
Wakabayashi S (2013) New insights into the functions of histidine-rich glycoprotein. Int Rev Cell Mol Biol 304:467–493. https://doi.org/10.1016/B978-0-12-407696-9.00009-9
Sabbatini AR, Mattii L, Battolla B, Polizzi E, Martini D, Ranieri-Raggi M, Moir AJ, Raggi A (2011) Evidence that muscle cells do not express the histidine-rich glycoprotein associated with AMP deaminase but can internalise the plasma protein. Eur J Histochem. https://doi.org/10.4081/ejh.2011.e6
Tugues S, Roche F, Noguer O, Orlova A, Bhoi S, Padhan N, Akerud P, Honjo S, Selvaraju RK, Mazzone M, Tolmachev V, Claesson-Welsh L (2014) Histidine-rich glycoprotein uptake and turnover is mediated by mononuclear phagocytes. PLoS ONE. https://doi.org/10.1371/journal.pone.0107483
Ranieri-Raggi M, Raggi A (1979) Regulation of skeletal muscle AMP deaminase: effects of limited proteolysis on the activity of the rabbit enzyme. FEBS Lett 102:59–63. https://doi.org/10.1016/0014-5793(79)80928-x
Ranieri-Raggi M, Raggi A (1990) Regulation of skeletal-muscle AMP deaminase. Evidence for a highly pH-dependent inhibition by ATP of the homogeneous derivative of the rabbit enzyme yielded by limited proteolysis. Biochem J 272:755–759. https://doi.org/10.1042/bj2720755
Ronca F, Ranieri-Raggi M, Brown PE, Moir AJ, Raggi A (1994) Evidence of a species-differentiated regulatory domain within the N-terminal region of skeletal muscle AMP deaminase. Biochim Biophys Acta 1209:123–129. https://doi.org/10.1016/0167-4838(94)90147-3
Ranieri-Raggi M, Raggi A (1980) Effects of storage on activity and subunit structure of rabbit skeletal-muscle AMP deaminase. Biochem J 189:367–368. https://doi.org/10.1042/bj1890367
Mahnke-Zizelman DK, Tullson PC, Sabina RL (1998) Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms. J Biol Chem 273:35118–35125. https://doi.org/10.1074/jbc.273.52.35118
Emori Y, Kawasaki H, Imajoh S, Imahori K, Suzuki K (1987) Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc Natl Acad Sci USA 84:3590–3594. https://doi.org/10.1073/pnas.84.11.3590
Ronca F, Raggi A (2022) Regulation of skeletal muscle AMP deaminase. Carbethoxylation of His-51 belonging to the zinc coordination sphere of the rabbit enzyme promotes its desensitization towards the inhibition by ATP. Biochim Biophys Acta. https://doi.org/10.1016/j.bbagen.2021.130044
Currie RD, Webster HL (1962) Preparation of 5’-adenylic acid deaminase based on phosphate-induced dissociation of rat actomyosin-deaminase complexes. Biochim Biophys Acta 64:30–40. https://doi.org/10.1016/0006-3002(62)90757-6
Shiraki H, Miyamoto S, Matsuda Y, Momose E, Nakagawa H (1981) Possible correlation between binding of muscle type AMP deaminase to myofibrils and ammoniagenesis in rat skeletal muscle on electrical stimulation. Biochem Biophys Res Commun 100:1099–1103. https://doi.org/10.1016/0006-291x(81)91936-7
Rundell KW, Tullson PC, Terjung RL (1992) AMP deaminase binding in contracting rat skeletal muscle. Am J Physiol 263:C287–C293. https://doi.org/10.1152/ajpcell.1992.263.2.C287
Rundell KW, Tullson PC, Terjung RL (1993) AMP deaminase binding in rat skeletal muscle after high-intensity running. J Appl Physiol 74:2004–2006. https://doi.org/10.1152/jappl.1993.74.4.2004
van Kuppevelt TH, Veerkamp JH, Fishbein WN, Ogasawara N, Sabina RL (1994) Immunolocalization of AMP-deaminase isozymes in human skeletal muscle and cultured muscle cells: concentration of isoform M at the neuromuscular junction. J Histochem Cytochem 42:861–868. https://doi.org/10.1177/42.7.8014469
Ashby B, Frieden C, Bischoff R (1979) Immunofluorescent and histochemical localization of AMP deaminase in skeletal muscle. J Cell Biol 81:361–373. https://doi.org/10.1083/jcb.81.2.361
Hu LY, Ackermann MA, Kontrogianni-Konstantopoulos A (2015) The sarcomeric M-region: a molecular command center for diverse cellular processes. Biomed Res Int. https://doi.org/10.1155/2015/714197
Cooper J, Trinick J (1984) Binding and location of AMP deaminase in rabbit psoas muscle myofibrils. J Mol Biol 177:137–152. https://doi.org/10.1016/0022-2836(84)90061-5
Koretz JF, Irving TC, Wang K (1993) Filamentous aggregates of native titin and binding of C-protein and AMP-deaminase. Arch Biochem Biophys 304:305–309. https://doi.org/10.1006/abbi.1993.1354
Ranieri-Raggi M, Moir AJ, Raggi A (2014) The role of histidine-proline-rich glycoprotein as zinc chaperone for skeletal muscle AMP deaminase. Biomolecules 4:474–497. https://doi.org/10.3390/biom4020474
Sabbatini AR, Ranieri-Raggi M, Pollina L, Viacava P, Ashby JR, Moir AJ, Raggi A (1999) Presence in human skeletal muscle of an AMP deaminase-associated protein that reacts with an antibody to human plasma histidine-proline-rich glycoprotein. J Histochem Cytochem 47:255–260. https://doi.org/10.1177/0022155499047002140
Sabbatini AR, Toscano A, Aguennouz M, Martini D, Polizzi E, Ranieri-Raggi M, Moir AJ, Migliorato A, Musumeci O, Vita G, Raggi A (2006) Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity. J Muscle Res Cell Motil 27:83–92. https://doi.org/10.1007/s10974-006-9059-4
Mattii L, Rossi L, Ippolito C, Alì G, Martini D, Raggi A, Sabbatini ARM (2017) Immunohistochemical localization of histidine-rich glycoprotein in human skeletal muscle: preferential distribution of the protein at the sarcomeric I-band. Histochem Cell Biol 148:651–657. https://doi.org/10.1007/s00418-017-1594-0
Guan X, Juarez JC, Qi X, Shipulina NV, Shaw DE, Morgan WT, McCrae KR, Mazar AP, Doñate F (2004) Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells. Thromb Haemost 92:403–412. https://doi.org/10.1160/TH04-02-0073
Mattii L, Bianchi F, Falleni A, Frascarelli S, Masini M, Alì G, Chiellini G, Sabbatini ARM (2020) Ultrastructural localization of histidine-rich glycoprotein in skeletal muscle Fibers: colocalization with AMP deaminase. J Histochem Cytochem 68:139–148. https://doi.org/10.1369/0022155419897573
Thoden JB, Phillips GN Jr, Neal TM, Raushel FM, Holden HM (2001) Molecular structure of dihydroorotase: a paradigm for catalysis through the use of a binuclear metal center. Biochemistry 40:6989–6997. https://doi.org/10.1021/bi010682i
Benning MM, Kuo JM, Raushel FM, Holden HM (1994) Three-dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry 33:15001–15007. https://doi.org/10.1021/bi00254a008
Zielke CL, Suelter CH (1971) Rabbit muscle adenosine 50-monophosphate aminohydrolase. Characterization as a zinc metalloenzyme. J Biol Chem 246:2179–2186
Merkler DJ, Schramm VL (1988) ATP binding site in yeast AMP deaminase. FASEB J 2:A552
Raggi A, Ranieri M, Taponeco G, Ronca-Testoni S, Ronca G, Rossi CA (1970) Interaction of rat muscle AMP aminohydrolase with chelating agents and metal ions. FEBS Lett 10:101–104. https://doi.org/10.1016/0014-5793(70)80426-4
Gupta RS, Suggett C (2022) Conserved signatures in protein sequences reliably demarcate different clades of rodents/glires species and consolidate their evolutionary relationships. Genes 13:288. https://doi.org/10.3390/genes13020288
Hemphill RM, Zielke CL, Suelter CH (1971) 5’-adenosine monophosphate aminohydrolase. Evidence for anomalous substrate saturation kinetics at low enzyme concentrations. J Biol Chem 246:7237–7240
Lamb AL, Torres AS, O’Halloran TV, Rosenzweig AC (2001) Heterodimeric structure of superoxide dismutase in complex with its metallochaperone. Nat Struct Biol 8:751–755. https://doi.org/10.1038/nsb0901-751
Cao T, Thongam U, Jin JP (2019) Invertebrate troponin: insights into the evolution and regulation of striated muscle contraction. Arch Biochem Biophys 666:40–45. https://doi.org/10.1016/j.abb.2019.03.013
Bullard B, Leonard K, Larkins A, Butcher G, Karlik C, Fyrberg E (1988) Troponin of asynchronous flight muscle. J Mol Biol 204:621–637. https://doi.org/10.1016/0022-2836(88)90360-9
Marden JH, Fitzhugh GH, Wolf MR, Arnold KD, Rowan B (1999) Alternative splicing, muscle calcium sensitivity, and the modulation of dragonfly flight performance. Proc Natl Acad Sci U S A 96:15304–15309. https://doi.org/10.1073/pnas.96.26.15304
Zhu J, Sun Y, Zhao FQ, Yu J, Craig R, Hu S (2009) Analysis of tarantula skeletal muscle protein sequences and identification of transcriptional isoforms. BMC Genomics 10:117. https://doi.org/10.1186/1471-2164-10-117
Cao T, Sujkowski A, Cobb T, Wessells RJ, Jin JP (2020) The glutamic acid-rich-long C-terminal extension of troponin T has a critical role in insect muscle functions. J Biol Chem 295:3794–3807. https://doi.org/10.1074/jbc.RA119.012014
Lipscomb WN, Sträter N (1996) Recent advances in zinc enzymology. Chem Rev 96:2375–2434. https://doi.org/10.1021/cr950042j
Fukasawa K, Fukasawa KM, Iwamoto H, Hirose J, Harada M (1999) The HELLGH motif of rat liver dipeptidyl peptidase III is involved in zinc coordination and the catalytic activity of the enzyme. Biochemistry 38:8299–8303. https://doi.org/10.1021/bi9904959
Jin JP, Chen A, Ogut O, Huang QQ (2000) Conformational modulation of slow skeletal muscle troponin T by an NH(2)-terminal metal-binding extension. Am J Physiol Cell Physiol 279:C1067–C1077. https://doi.org/10.1152/ajpcell.2000.279.4.C1067
Fredericks S, Degens H, McKoy G, Bainbridge K, Collinson PO, Coulton G, Elmahdi H, Holt DW (2007) Effect of denervation on the content of cardiac troponin-T and cardiac troponin-I in rat skeletal muscle. Clin Biochem 40:423–426. https://doi.org/10.1016/j.clinbiochem.2006.12.008
Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18(1):39–51. https://doi.org/10.1096/fj.03-0610com
Fortuin FD, Morisaki T, Holmes EW (1996) Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle. Proc Assoc Am Phys 108:329–333
Magneson GR, Puvathingal JM, Ray WJ Jr (1987) The concentrations of free Mg2+ and free Zn2+ in equine blood plasma. J Biol Chem 262:11140–11148
Bendall JR, Davey CL (1957) Ammonia liberation during rigor mortis and its relation to changes in the adenine and inosine nucleotides of rabbit muscle. Biochim Biophys Acta 26:93–103. https://doi.org/10.1016/0006-3002(57)90059-8
Brach JS, VanSwearingen J (1995) Measuring fatigue related to facial muscle function. Arch phys med rehab 76:905–908. https://doi.org/10.1016/s0003-9993(95)80064-6
Funding
Open access funding provided by Università di Pisa within the CRUI-CARE Agreement. This work was supported by Fondi di Ateneo, University of Pisa.
Author information
Authors and Affiliations
Contributions
All authors interpreted data, critically revised the manuscript, provided intellectual and scientific contributions, and approved the final version of the manuscript submitted for publication.
Corresponding author
Ethics declarations
Conflicts of interests
The authors declare no conflicts of interests, financial or otherwise.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ronca, F., Raggi, A. Role of the interaction between troponin T and AMP deaminase by zinc bridge in modulating muscle contraction and ammonia production. Mol Cell Biochem 479, 793–809 (2024). https://doi.org/10.1007/s11010-023-04763-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-023-04763-7